011HO15467 ALTAMAGNIFIQUE

Print/PDF
Registration Name PEAK ALTAMAGNIFIQUE-ET
Registration Number HO840003213001110
Primary NAAB Code 011HO15467
Secondary Code(s) 511HO15467, 752HO15467, 122HO15467
Status Inactive
Controller Name Alta Genetics (11)
Date of Birth 1/20/2020
aAa 423
DMS 123,126
GFI 12.4%
Genetic Codes * TY TC TD TV TL TR TP MW
Haplotypes
Sire PROGENESIS MAESTRO-ET
MGS PROGENESIS POSITIVE
Beta Casein A1A2
Kappa Casein AB
Beta Lactoglobulin AB
INDEXES
NM$ 442, 91% R CM$ 478
NM Percentile 44% FM$ 356
GTPI 2942 GM$ 391
PRODUCTION TRAITS
4622 Dtrs 647 herds 26 % US 99% R
Milk 424 Fat, % 56 , +0.14%
SCS 3.05, 98% R Protein, % 39 , +0.09%
Feed Saved -188 , 56% R Milking Speed 6.67 , 95% R
Health & Fertility
Productive Life 1.7      96% R Mastitis 0.5      92% R
Heifer Livability -1.3       78% R Metritis 1.9      91% R
Livability 1.5      85% R D. Abom 0.1      94% R
DPR -1.1      98% R Ketosis 0.5      89% R
FSC 0.6      98% R R. Placenta 1.6      91% R
HCR -0.2      95% R Milk Fever 0.1      80% R
CCR -0.6      98% R
SCR -        -
DIA -0.9      63% R
RSP -4.0      79% R
Calving Traits
Sire CE 1.1      98% R 4200 Obs
Daughter CE 1.1      97% R 788 Obs, 1886 Dtrs
Sire SB 3.7      96% R 6842 Obs
Daughter SB 3.4      96% R 713 Obs, Dtrs
Gestation Length -2.4      99% R 109 Obs, 2227 Dtrs
Early First Calving 5.0      95% R 88 Obs, 1060 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
1615 Dtrs 272 herds 97% R
PTA Type 0.11 UDC 0.47
HCC -0.07 BWC 1.31
FLC -0.63
Linear Traits
Stature 0.41
Tall
Strength 0.92
Strong
Body Depth 0.39
Deep
Dairy Form -0.67
Closed
Rump Angle 2.49
Sloped
Thurl Width 1.24
Sloped
Rear Legs-Side View 1.24
Wide
Rear Legs-Rear View -0.56
H.-in
Foot Angle 0.61
Steep
Feet & Legs Score -0.54
Low
F.U. Attachment -0.70
Straight
Rear Udder Height 0.33
High
Rear Udder Width 0.56
Wide
Udder Cleft 0.13
Strong
Udder Depth -0.56
H.-in
Front Teat Placement 1.58
Close
Rear Teat Placement 2.05
Close
Teat Length -1.65
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO